Form 4: Dyadic Director Jack Kaye Reports Equity Transactions
Insider Transaction Report
Dyadic International Director Jack Kaye reported the settlement of previously vested restricted stock units into common stock and received new annual grants of stock options and restricted stock units.
Summary
- Jack Kaye, a Director of Dyadic International Inc. (DYAI), reported changes in his beneficial ownership.
- On January 2, 2026, 21,552 restricted stock units (RSUs) that had previously vested were settled into common stock.
- Following this settlement, Kaye beneficially owns 81,201 shares of common stock directly.
- Kaye also received an annual grant of 67,500 stock options with an exercise price of $0.94, exercisable from January 2, 2027, and expiring on January 2, 2036.
- Additionally, Kaye received an annual grant of 39,894 restricted stock units, which will vest and settle into common stock on the first anniversary of the grant date (January 2, 2027), subject to continued service as a board member.
Sentiment
Score: 6
Explanation: The filing reports routine equity compensation for a director, including the settlement of vested restricted stock units and new grants of stock options and restricted stock units. This indicates continued alignment of the director's interests with the company's performance.
Positives
- Director Jack Kaye received new annual grants of 67,500 stock options and 39,894 restricted stock units, aligning his interests with shareholders.
- The settlement of 21,552 previously vested restricted stock units into common stock increases the director's direct ownership of the company's equity.
Risks
- The value of the newly granted stock options and restricted stock units is subject to the future performance of Dyadic International Inc.'s common stock.
- The vesting of the 39,894 restricted stock units is contingent upon continued service as a member of the board of directors.
Future Outlook
The 39,894 restricted stock units granted on January 2, 2026, are expected to vest and settle into common stock on January 2, 2027, subject to continued service. The 67,500 stock options granted on January 2, 2026, will become exercisable on January 2, 2027, and expire on January 2, 2036.
Industry Context
This filing is a standard report of insider equity transactions and does not provide information related to broader industry trends or competitors. Equity grants are a common practice for executive and director compensation across various industries to align interests with shareholders.
Stakeholder Impact
- Shareholders: The grants of stock options and restricted stock units align the director's financial interests with shareholder value creation.
Next Steps
- The 39,894 restricted stock units are scheduled to vest on January 2, 2027, contingent on continued service.
- The 67,500 stock options will become exercisable on January 2, 2027.
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Transaction Date for settlement of 21,552 RSUs into common stock, grant of 67,500 stock options, and grant of 39,894 RSUs. |
| 01/06/2026 | Date the Form 4 was signed by attorney-in-fact. |
| 01/02/2027 | Date the 67,500 stock options become exercisable; First anniversary of grant date for 39,894 RSUs, upon which they will vest and settle. |
| 01/02/2036 | Expiration Date for the 67,500 stock options. |
Keywords
Dyadic International Inc., DYAI, Jack Kaye, Director, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Equity Grant, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.